• Calpain Inhibitor I, ALLN: Lab Guide

  2026-09-22

  Calpain Inhibitor I, ALLN (SKU A2602) provides an experimental way to inhibit calpain I, calpain II, and selected cathepsins in apoptosis, inflammation, and ischemia-reperfusion workflows. It should be used with vehicle, viability, and pathway controls rather than treated as a calpain-specific diagnostic, therapeutic, or stand-alone mechanistic probe.

• (+)-Bicuculline: Practical Protocol & QC

  2026-09-22

  This guide explains how to prepare, store, and apply (+)-Bicuculline as a GABAA receptor antagonist in neuronal and synaptic signaling workflows. It is a research reagent only; the dossier-supported in vivo context should not be treated as a clinical, diagnostic, or universal dosing protocol.

• HyperScribe All in One mRNA Synthesis Kit Guide

  2026-09-21

  The HyperScribe All in One mRNA Synthesis Kit combines T7 transcription, co-transcriptional ARCA capping, DNase treatment, and enzymatic poly(A) tailing for translation-ready mRNA. Its unified workflow supports mRNA vaccine synthesis, in vitro translation mRNA preparation, antisense RNA synthesis, and RNA interference experiments while keeping RNA production distinct from delivery-system optimization.

• Molidustat (BAY85-3934) for Renal Anemia

  2026-09-21

  Molidustat (BAY85-3934) is a HIF prolyl hydroxylase inhibitor that stabilizes hypoxia-inducible factor signaling and supports endogenous erythropoietin research. Its reported isoform IC50 values, oxygen-sensing mechanism, CKD-anemia relevance, and formulation limits define a practical translational profile.

• G-1: Selective GPR30 Agonist

  2026-09-20

  G-1 is a selective GPR30 agonist for studying rapid GPER1 signaling without substantial classical ERα or ERβ engagement. Product and preclinical evidence supports applications in cardiovascular models, breast cancer cell migration, and receptor-defined neuroscience workflows.

• Tacalcitol Monohydrate: A Response-First Guide

  2026-09-19

  Tacalcitol monohydrate is a synthetic analog of vitamin D3 with applications spanning keratinocyte biology, NGF induction, and colorectal cancer research. This evidence-led guide explains how to select endpoints, interpret VDR-dependent responses, and design studies combining tacalcitol with 5-fluorouracil.

• EZ Cap EGFP mRNA 5-moUTP Workflow Guide

  2026-09-18

  Learn how to use EZ Cap EGFP mRNA 5-moUTP as a reproducible fluorescent benchmark for transfection, translation, cell viability, and delivery studies. The workflow connects Cap1 and 5-moU chemistry with practical LNP screening, including lessons from machine-learning-guided microglia research.

• Molidustat and the HIF Oxygen-Sensing Opportunity

  2026-09-18

  Molidustat (BAY85-3934) offers a mechanistically precise way to study HIF-PH inhibition, endogenous erythropoietin stimulation, and chronic kidney disease anemia. This thought-leadership perspective connects its renal anemia research potential with the Septin4–VHL–HIF-1α axis, while defining practical validation steps and translational limits.

• Z-VAD-FMK Workflows for Apoptosis Research

  2026-09-17

  Z-VAD-FMK enables controlled testing of whether a cell-death phenotype depends on caspase signaling, with practical value in immune-cell, transcriptional-stress, and cancer research models. This guide combines workflow design, assay interpretation, storage guidance, and troubleshooting for more defensible apoptosis inhibition experiments.

• Cy7 NHS Ester: Practical Protein Labeling Guide

  2026-09-17

  Cy7 NHS ester (SKU A8109) is a water-soluble near-infrared dye for bioimaging that labels accessible primary amines on proteins and peptides. It is suited to aqueous biomolecule conjugation and live-animal or cellular tracking workflows, but it should not be used as a universal cell stain or stored as a prepared solution for extended periods.

• Antiresistance AR Antagonists for Prostate Cancer

  2026-09-16

  The reference study identifies a new strategy for overcoming androgen receptor resistance by targeting the receptor dimer interface rather than the mutation-prone ligand-binding pocket. Through optimization of the M17-B15 series, the authors discovered Y5, a compound that combines AR dimerization disruption with ubiquitin–proteasome-dependent AR degradation and suppresses LNCaP xenograft growth after oral administration.

• A-1210477 MCL-1 Inhibitor Workflow

  2026-09-16

  Build a mechanism-first in vitro workflow around A-1210477 to distinguish MCL-1-dependent survival from nonspecific cytotoxicity. The guide combines dose-response, mitochondrial apoptosis, BAX/BAK-informed validation, and combination testing with practical handling and troubleshooting advice.

• Ibotenic Acid Toxicity in Mice: Dose and Time

  2026-09-15

  A 2026 study in mice provides an integrated analysis of ibotenic acid toxicity across behavior, blood biochemistry, histopathology, and immunohistochemistry. Its findings distinguish transient abnormalities at 16 mg/kg from severe, potentially fatal toxicity at 33 mg/kg and identify early c-fos activation and reduced Nissl bodies as useful indicators of neural injury.

• Ibotenic Acid: From Toxicity to Assay Design

  2026-09-15

  Ibotenic acid is an NMDA receptor agonist with value beyond disease modeling. This guide translates dose- and time-dependent mouse toxicity findings into practical assay-design, formulation, storage, and interpretation decisions.

• Pemetrexed: A DNA-Repair-Aware Research Framework

  2026-09-14

  Pemetrexed research is most informative when antifolate stress is interpreted alongside DNA-repair phenotype. This guide connects pemetrexed disodium mechanism, malignant mesothelioma models, and assay design using findings from a landmark homologous-recombination study.

8568 records 1/572 page Next 12345 下5页 Last page